1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United Kingdom >
  5. Sysmex Acquires Oxford Gene Technology IP

M&A Deal Summary

Sysmex Acquires Oxford Gene Technology IP

On May 31, 2017, Sysmex acquired life science company Oxford Gene Technology IP

Acquisition Highlights
  • This is Sysmex’s 1st transaction in the Life Science sector.
  • This is Sysmex’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2017-05-31
Target Oxford Gene Technology IP
Sector Life Science
Buyer(s) Sysmex
Deal Type Add-on Acquisition

Target

Oxford Gene Technology IP

Begbroke, United Kingdom
Oxford Gene Technology IP Ltd. is a developer of molecular genetics research and biomarker solutions for clinical and academic research institutions. Oxford Gene Technology IP Ltd. was founded in 1995 and is based in Begbroke, UK.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sysmex

Kobe, Japan
Category Company
Founded 1968
Sector Medical Products
Employees10,533
Revenue 508.6B JPY (2025)
DESCRIPTION

Sysmex is a developer, manufacturer, and seller of laboratory testing reagents and laboratory equipment; the development and sale of computer systems for medical institutions, as well as the development and sale of software used for clinical examination information systems. Sysmex was founded in 1968 and is based in Kobe, Japan.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2017 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal